Request Trial
shutterstock_1651313599_dcstockphotography
DCStockPhotography / Shutterstock.com
13 January 2022MedTechAlex Baldwin

Arthrex petitions Fed Circ again over ‘inferior officers’

Arthrex says that it did not get the “remedy” ordered by the US Supreme Court in its landmark case against Smith & Nephew.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

MedTech
European court strikes down hearing aid sensor patent
30 July 2026   A dispute over optical sensor technology in miniature hearing devices ended with the EPO revoking a patent, finding the invention obvious despite ruling it was new over the closest prior art.
MedTech
Boston Scientific overturns $42m patent verdict on appeal
28 July 2026   Years of litigation over biodegradable drug-delivery technology took another turn after the Federal Circuit delivered a significant win for the medical device maker.
MedTech
AbbVie, Allergan takes on Swiss aesthetics rival over syringe design
23 July 2026   The latest clash between two facial aesthetics rivals centres on a Swiss rival’s newly approved syringe, which AbbVie and Allergan claim infringes five US design patents.


Editor's picks

Where Big Pharma is betting big in the M&A boom
Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

Editor's picks

Regulation & Industry
Where Big Pharma is betting big in the M&A boom
29 July 2026

More features

USPTO director steps into Sun Pharma’s PTAB-ITC clash
USPTO appoints new acting commissioner for patents
European court strikes down hearing aid sensor patent
Where Big Pharma is betting big in the M&A boom
Fish & Richardson adds AI and medical device specialist
Boston Scientific overturns $42m patent verdict on appeal
Buying the brains: Why is Big Pharma shopping for innovation?
FisherBroyles and Hong Kong affiliate draft in senior partners